TABLE OF CONTENTS | April 2013 Volume 9, Issue 4 |  |  |  |  | Focus Editorial Commentaries Research Highlights News and Views Perspective Review Brief Communications Articles
| |  | |  |  | Advertisement |  | Submit to Nature Chemical Biology The editorial team welcomes contributions from academic, industrial and government sectors across all areas of chemical biology. To submit your next paper to Nature Chemical Biology visit the electronic submission website at: http://mts-nchemb.nature.com/cgi-bin/main.plex | |  | | Focus | Top |  |  |  | Targets In this issue, we present a collection of articles that tackle the challenges in the discovery and validation of new targets for clinical purposes, the application of chemical probes to understand the relationship between targets and biology and the expanding assortment of chemical tools and techniques that can be used to perturb targets that have been considered chemically intractable. Targets |  | Editorial | Top |  |  |  | Stay on target p193 doi:10.1038/nchembio.1226 Applying a rigorous chemical biology approach to the selection and validation of clinical targets will increase the success of drug discovery initiatives. |  | Commentaries | Top |  |  |  | Target validation using chemical probes pp195 - 199 Mark E Bunnage, Eugene L Piatnitski Chekler and Lyn H Jones doi:10.1038/nchembio.1197 Fully profiled chemical probes are essential to support the unbiased interpretation of biological experiments necessary for rigorous preclinical target validation. We believe that by developing a 'chemical probe tool kit', and a framework for its use, chemical biology can have a more central role in identifying targets of potential relevance to disease, avoiding many of the biases that complicate target validation as practiced currently.
|  |  |  | Determining target engagement in living systems pp200 - 205 Gabriel M Simon, Micah J Niphakis and Benjamin F Cravatt doi:10.1038/nchembio.1211 Chemical probes are critical tools for elucidating the biological functions of proteins and can lead to new medicines for treating disease. The pharmacological validation of protein function requires verification that chemical probes engage their intended targets in vivo. Here we discuss technologies, both established and emergent, for measuring target engagement in living systems and propose that determining this parameter should become standard practice for chemical probe and drug discovery programs.
|  |  |  | The why and how of phenotypic small-molecule screens pp206 - 209 Ulrike S Eggert doi:10.1038/nchembio.1206 Small-molecule phenotypic screening has high potential in the discovery of new chemical probes and new biological small-molecule targets. This commentary will discuss the basic principles underlying the design of phenotypic screens and propose some guidelines to facilitate the discovery of small molecules from phenotypic screens.
|  |  |  | Translational synthetic chemistry pp210 - 213 Sarathy Kesavan and Lisa A Marcaurelle doi:10.1038/nchembio.1207 Providing chemical matter to modulate newly identified biological targets[mdash]as well as pre-existing but chemically intractable ones[mdash]remains a challenge in the discovery of therapeutics. Here, we discuss opportunities for synthetic chemists to make a direct impact in addressing targets that are considered 'undruggable'.
|  | Research Highlights | Top |  |  |  | Neuroscience: Tracing glutamate | Heterocycles: Stitching in selenium | Transcriptional regulation: Find that factor | Pluripotency: Tet à tet | Metabolism: RNA talks back | Drug discovery: Hits for Tat | Biosynthesis: Served with a twist | Plant signaling: Flowers from a sweetheart | News and Views | Top |  |  |  | |  | Perspective | Top |  |  |  | Systems-level antimicrobial drug and drug synergy discovery pp222 - 231 Terry Roemer and Charles Boone doi:10.1038/nchembio.1205
|  | Review | Top |  |  |  | Target identification and mechanism of action in chemical biology and drug discovery pp232 - 240 Monica Schenone, Vlado DanÄík, Bridget K Wagner and Paul A Clemons doi:10.1038/nchembio.1199
|  | Brief Communications | Top |  |  |  | |  |  |  | |  |  |  | |  | Articles | Top |  |  |  | Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells pp250 - 256 Scott Barbuto, Juliana Idoyaga, Miquel Vila-Perelló, Maria P Longhi, Gaëlle Breton, Ralph M Steinman and Tom W Muir doi:10.1038/nchembio.1186

A conjugate generated by expressed protein ligation between an antibody targeting dendritic cells (DCs) and an immune-stimulating double-stranded DNA reveals that DCs can mediate both innate and adaptive immunity and represents its potential utility as a vaccine adjuvant.
|
|
|  |  |  | Photochemical activation of TRPA1 channels in neurons and animals pp257 - 263 David Kokel, Chung Yan J Cheung, Robert Mills, Jaeda Coutinho-Budd, Liyi Huang, Vincent Setola, Jared Sprague, Shan Jin, Youngnam N Jin, Xi-Ping Huang, Giancarlo Bruni, Clifford J Woolf, Bryan L Roth, Michael R Hamblin, Mark J Zylka, David J Milan and Randall T Peterson doi:10.1038/nchembio.1183

Optovin is a small molecule that renders zebrafish embryos responsive to light through generation of singlet oxygen and activation of the TrpA1b channel, providing a new tool for optogenetics.
See also: News and Views by Fajardo & Friedrich |
|
|  |  |  | |  |  |  | Allosteric inhibition of hypoxia inducible factor-2 with small molecules pp271 - 276 Thomas H Scheuermann, Qiming Li, He-Wen Ma, Jason Key, Lei Zhang, Rui Chen, Joseph A Garcia, Jacinth Naidoo, Jamie Longgood, Doug E Frantz, Uttam K Tambar, Kevin H Gardner and Richard K Bruick doi:10.1038/nchembio.1185

A new small-molecule inhibitor that selectively binds an internal cavity in HIF-2α allosterically disrupts HIF-2α–ARNT interaction in vitro and in cells. This compound should allow scientists to interrogate HIF-2α's activity in hypoxia and cancer cells. Chemical compounds |
|
|  |  |  | Lysine and arginine biosyntheses mediated by a common carrier protein in Sulfolobus pp277 - 283 Takuya Ouchi, Takeo Tomita, Akira Horie, Ayako Yoshida, Kento Takahashi, Hiromi Nishida, Kerstin Lassak, Hikari Taka, Reiko Mineki, Tsutomu Fujimura, Saori Kosono, Chiharu Nishiyama, Ryoji Masui, Seiki Kuramitsu, Sonja-Verena Albers, Tomohisa Kuzuyama and Makoto Nishiyama doi:10.1038/nchembio.1200

One pathway for lysine biosynthesis uses a carrier protein, LysW, to protect the substrate. LysW is now shown to mediate entry of a second substrate into the same metabolic pathway, with structural and biochemical evidence identifying an amino acid motif that determines substrate specificity.
|
|
|  | Top |  |  | Advertisement |  | |  | |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | |
|
No comments:
Post a Comment